Betahistine mesilate

Amubarvimab (anti-Spike RBD) is a human IgG1 mAb that bind to non-competing epitopes on the receptor binding domain (RBD) of spike protein, with a KD of 5.88 nM.

Amubarvimab (anti-Spike RBD) is a human IgG1 mAb that bind to non-competing epitopes on the receptor binding domain (RBD) of spike protein, with a KD of 5.88 nM.

Amubarvimab (anti-Spike RBD) is a human IgG1 mAb that bind to non-competing epitopes on the receptor binding domain (RBD) of spike protein, with a KD of 5.88 nM.

Amubarvimab (anti-Spike RBD) is a human IgG1 mAb that bind to non-competing epitopes on the receptor binding domain (RBD) of spike protein, with a KD of 5.88 nM.

Immunogen Peptide with sequence C-QAAVDGPMDKKEE from the C Terminus of the protein sequence according to NP_005736.3.

Specificity Recognizes Hey 1 / HRT1, a Helix-loop-helix class of transcription factor. Immunogen Synthetic peptide, amino acids 207-220 of human Hey 1 / HRT1.

Immunogen Antibody was raised against a 19 amino acid peptide near the amino terminus of human HHATL. Features and Benefits Evaluate our antibodies with complete peace of mind.

SPIRE1 (spire type actin nucleation factor 1) is a modular protein, that has a cluster of four actin-binding WH2 (wasp-homology 2) domains. It belongs to the SPIRE family of actin nucleators.

Anti-Swine H1N1 Neuraminidase Antibody has been tested for use in ELISA. Specific conditions for reactivity should be optimized by the end user. Expect a band at approximately 52 kDa in Western Blots of specific cell lysates and tissues.

Immunogen Antibody was raised against a 19 amino acid peptide near the carboxy terminus of human TYW1. Features and Benefits Evaluate our antibodies with complete peace of mind.

General description This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the

Galegenimab (anti-HTRA1), an anti-High-temperature requirement A1 (HTRA1) antibody fragment. Galegenimab (anti-HTRA1) can be used for age-related macular degeneration (AMD) research.